You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,107,921


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,107,921 protect, and when does it expire?

Patent 9,107,921 protects TUXARIN ER and is included in one NDA.

Summary for Patent: 9,107,921
Title:Oral dosage forms for oxygen containing active agents and oxyl-containing polymers
Abstract: A pharmaceutical tablet for oral administration once every 12 hours is provided. The tablet includes a first active agent that is a tri-oxy active agent, a second active agent, and a release rate controlling non-ionic oxyl-containing hydrophilic polymer. The tablet is a matrix tablet and a single-dose administration of one or more tablets to a subject under fasted conditions provides a mean Cm.about. for each of the first active agent and the second active agent that is 70% to 135% of a respective mean Cm.about. provided by administering an immediate release oral dosage form to a subject under fasted conditions every 4 to 6 hours over a 12 hour time period, wherein cumulative dosage amounts administered over the 12 hour time period of each active agent is equivalent to the respective amount of each active agent in the pharmaceutical tablet.
Inventor(s): Giliyar; Chandrashekar (North Maple Grove, MN), Nachaegari; Satish Kumar (Salt Lake City, UT), Machiappan; Chidambaram (Salt Lake City, UT), Patel; Mahesh V. (Salt Lake City, UT), Venkateshwaran; Srinivasan (Salt Lake City, UT)
Assignee: Spriaso LLC (Salt Lake City, UT)
Application Number:14/555,043
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 9,107,921

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 9,107,921, using it as a case study to explain the key concepts and processes involved in patent claims and scope.

What is a Patent?

A patent is a government-granted monopoly that gives the inventor the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date. In the United States, the patent system is governed by the United States Patent and Trademark Office (USPTO)[1].

Determining Inventorship

Before diving into the specifics of a patent, it is essential to understand who the true and only inventors are. US patent law requires that only those who conceived the idea or subject matter of the patent claims be listed as inventors. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention[2].

Patent Claims

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. There are two main types of claims: independent claims and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more comprehensive. For example, in US Patent 9,107,921, the independent claims would outline the core aspects of the invention without relying on other claims[3].

Dependent Claims

Dependent claims refer back to and further limit an independent claim. They are narrower and often specify particular embodiments or features of the invention. These claims are used to provide additional detail and protection for specific aspects of the invention.

Measuring Patent Scope

The scope of a patent is a critical aspect that determines the breadth of protection it offers. Two simple metrics often used to measure patent scope are independent claim length and independent claim count.

Independent Claim Length

Longer independent claims generally indicate a narrower scope, as they include more specific details and limitations. Conversely, shorter independent claims may suggest a broader scope but also increase the risk of being deemed overly broad and thus invalid[3].

Independent Claim Count

The number of independent claims can also indicate the scope of the patent. More independent claims may suggest a broader invention with multiple distinct aspects, while fewer claims might indicate a more focused invention.

The Examination Process

The journey from a patent application to a granted patent involves a rigorous examination process. Here are some key aspects:

First-Action Allowance Rate

This rate indicates the proportion of progenitor applications allowed without further examination. A higher first-action allowance rate suggests that the patent office finds the claims clear and well-supported by the specification[4].

Progenitor Allowance Rate

This rate measures the proportion of progenitor applications allowed without any continuation procedure. It provides insight into the overall success rate of patent applications[4].

Family Allowance Rate

This rate includes the outcomes of continuation applications that emerge from progenitor applications. It gives a comprehensive view of how many applications ultimately result in at least one granted patent[4].

Case Study: US Patent 9,107,921

To illustrate these concepts, let's consider US Patent 9,107,921, though the specific details of this patent are not provided here. Here’s a general approach to analyzing such a patent:

Identifying the Inventors

Ensure that the listed inventors are the true and only inventors who conceived the idea. Errors in inventorship can lead to invalidation of the patent if there was deceptive intent[2].

Analyzing the Claims

  • Independent Claims: Identify the broadest claims that define the core of the invention.
  • Dependent Claims: Look at how these claims further limit and specify the invention.

Understanding the Scope

  • Claim Length and Count: Evaluate the length and number of independent claims to gauge the patent's scope.
  • Examination History: Review the patent's examination history to see if it was allowed without significant amendments or if it went through multiple continuations[4].

Global Dossier and Public Search Facilities

For a comprehensive analysis, tools like the Global Dossier and the USPTO Public Search Facility are invaluable.

Global Dossier

This service provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family, dossier, classification, and citation data for the applications[1].

Public Search Facility

The USPTO Public Search Facility offers access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users in their searches[1].

The Importance of Correct Inventorship and Claim Drafting

Correct inventorship and well-drafted claims are crucial for the validity and enforceability of a patent.

Consequences of Incorrect Inventorship

Incorrect or deceptive inventorship can lead to the patent being declared unenforceable, even if the correct inventorship can be established later[2].

Impact of Claim Drafting

Poorly drafted claims can result in patents being deemed overly broad or lacking clarity, which can diminish their validity and increase litigation costs[3].

The Need for a Small Claims Patent Court

The complexity and costs associated with patent litigation have led to discussions about establishing a small claims patent court. This would provide a more accessible and cost-effective forum for resolving patent disputes, particularly for small entities[5].

Key Takeaways

  • Inventorship: Correctly identifying the true and only inventors is crucial for the validity of a patent.
  • Claims: Independent and dependent claims define the scope of the invention, with independent claims being broader and more comprehensive.
  • Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope.
  • Examination Process: Understanding the different allowance rates and the examination history provides insights into the patent's journey.
  • Search Tools: Utilizing tools like the Global Dossier and Public Search Facility can aid in comprehensive patent analysis.
  • Legal Implications: Correct inventorship and well-drafted claims are essential for the enforceability of a patent.

FAQs

Q: What is the significance of independent claims in a patent?

Independent claims define the core aspects of the invention and stand alone without reference to other claims. They are broader and more comprehensive.

Q: How does the Global Dossier help in patent research?

The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family, dossier, classification, and citation data.

Q: What are the consequences of incorrect inventorship in a patent application?

Incorrect or deceptive inventorship can lead to the patent being declared unenforceable, even if the correct inventorship can be established later.

Q: How do continuation applications affect the allowance rate of a patent?

Continuation applications can complicate the calculation of allowance rates, as they may result in multiple patents emerging from a single progenitor application.

Q: Why is there a discussion about establishing a small claims patent court?

The discussion is driven by the need for a more accessible and cost-effective forum for resolving patent disputes, particularly for small entities.

Sources

  1. USPTO: Search for patents - USPTO
  2. Oregon State University: Determining Inventorship for US Patent Applications
  3. SSRN: Patent Claims and Patent Scope
  4. Yale Journal of Law and Technology: What Is the Probability of Receiving a US Patent?
  5. Administrative Conference of the United States: U.S. Patent Small Claims Court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,107,921

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mainpointe TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 RX No No 9,107,921 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.